Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H27ClO5 |
Molecular Weight | 394.889 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C1=CC=C(OC[C@H](O)CO)C=C1)C2=CC=C(OC[C@H](O)CCl)C=C2
InChI
InChIKey=HDTYUHNZRYZEEB-QZTJIDSGSA-N
InChI=1S/C21H27ClO5/c1-21(2,15-3-7-19(8-4-15)26-13-17(24)11-22)16-5-9-20(10-6-16)27-14-18(25)12-23/h3-10,17-18,23-25H,11-14H2,1-2H3/t17-,18-/m1/s1
Molecular Formula | C21H27ClO5 |
Molecular Weight | 394.889 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1871 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20541699 | |
6.0 µM [IC50] |
PubMed
Title | Date | PubMed |
---|---|---|
Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. | 2010 Jun 15 |
|
EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer. | 2015 Feb 28 |
|
EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor. | 2016 Sep 16 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:17:20 GMT 2023
by
admin
on
Sat Dec 16 09:17:20 GMT 2023
|
Record UNII |
WC830G6O4X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C242
Created by
admin on Sat Dec 16 09:17:20 GMT 2023 , Edited by admin on Sat Dec 16 09:17:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID901019057
Created by
admin on Sat Dec 16 09:17:20 GMT 2023 , Edited by admin on Sat Dec 16 09:17:20 GMT 2023
|
PRIMARY | |||
|
C152147
Created by
admin on Sat Dec 16 09:17:20 GMT 2023 , Edited by admin on Sat Dec 16 09:17:20 GMT 2023
|
PRIMARY | |||
|
WC830G6O4X
Created by
admin on Sat Dec 16 09:17:20 GMT 2023 , Edited by admin on Sat Dec 16 09:17:20 GMT 2023
|
PRIMARY | |||
|
300000032398
Created by
admin on Sat Dec 16 09:17:20 GMT 2023 , Edited by admin on Sat Dec 16 09:17:20 GMT 2023
|
PRIMARY | |||
|
DE-98
Created by
admin on Sat Dec 16 09:17:20 GMT 2023 , Edited by admin on Sat Dec 16 09:17:20 GMT 2023
|
PRIMARY | |||
|
45107537
Created by
admin on Sat Dec 16 09:17:20 GMT 2023 , Edited by admin on Sat Dec 16 09:17:20 GMT 2023
|
PRIMARY | |||
|
1203490-23-6
Created by
admin on Sat Dec 16 09:17:20 GMT 2023 , Edited by admin on Sat Dec 16 09:17:20 GMT 2023
|
PRIMARY | |||
|
Ralaniten
Created by
admin on Sat Dec 16 09:17:20 GMT 2023 , Edited by admin on Sat Dec 16 09:17:20 GMT 2023
|
PRIMARY | |||
|
10676
Created by
admin on Sat Dec 16 09:17:20 GMT 2023 , Edited by admin on Sat Dec 16 09:17:20 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|